As a result, people with diabetes are especially at risk for the four types of eye diseases collectively called diabetic eye disease: diabetes-related retinopathy, diabetes-related macular edema, cataracts, and glaucoma
Patients considering GLP-1 receptor agonist or dual GIP/GLP-1 therapy should understand that these medications facilitate weight loss through appetite reduction and decreased food intake, not by "speeding up metabolism" or burning additional calories at rest
If you are pregnant, nursing, trying to conceive, taking any medications, planning a medical procedure or have a medical condition, please consult your healthcare practitioner before using this product
These fluctuations in temperature can damage the medication, reducing its effectiveness or making it unsafe to use